BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19459052)

  • 1. Chitosan-chondroitin sulfate based matrix tablets for colon specific delivery of indomethacin.
    Amrutkar JR; Gattani SG
    AAPS PharmSciTech; 2009; 10(2):670-7. PubMed ID: 19459052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of polyelectrolyte complexes between chondroitin sulfate and chitosan in the solid state.
    Chen WB; Wang LF; Chen JS; Fan SY
    J Biomed Mater Res A; 2005 Oct; 75(1):128-37. PubMed ID: 16041796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation of indomethacin colon targeted delivery systems using polysaccharides as carriers by applying liquisolid technique.
    Elkhodairy KA; Elsaghir HA; Al-Subayiel AM
    Biomed Res Int; 2014; 2014():704362. PubMed ID: 24971345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on stercuia gum formulations in the form of osmotic core tablet for colon-specific drug delivery of azathioprine.
    Nath B; Nath LK
    PDA J Pharm Sci Technol; 2013; 67(2):172-84. PubMed ID: 23569078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binders for colon specific drug delivery: an in vitro evaluation.
    Sinha VR; Kumria R
    Int J Pharm; 2002 Dec; 249(1-2):23-31. PubMed ID: 12433431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colon specific delivery of indomethacin: effect of incorporating pH sensitive polymers in xanthan gum matrix bases.
    Asghar LF; Chure CB; Chandran S
    AAPS PharmSciTech; 2009; 10(2):418-29. PubMed ID: 19381832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and evaluation of chondroitin sulphate tablets of aceclofenac for colon targeted drug delivery.
    Ramasamy T; Subbaih Khandasamy U; Shanmugam S; Ruttala H
    Iran J Pharm Res; 2012; 11(2):465-79. PubMed ID: 24250470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into the mechanisms of chitosan-anionic polymers-based matrix tablets for extended drug release.
    Li L; Wang L; Li J; Jiang S; Wang Y; Zhang X; Ding J; Yu T; Mao S
    Int J Pharm; 2014 Dec; 476(1-2):253-65. PubMed ID: 25290814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the development of colon-targeted delivery systems for celecoxib in the prevention of colorectal cancer.
    Krishnaiah YS; Satyanarayana V; Kumar BD; Karthikeyan RS
    J Drug Target; 2002 May; 10(3):247-54. PubMed ID: 12075826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site Targeted Press Coated Delivery of Methylprednisolone Using Eudragit RS 100 and Chitosan for Treatment of Colitis.
    Jagdale S; Chandekar A
    Recent Pat Antiinfect Drug Discov; 2016; 11(1):32-43. PubMed ID: 26377799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Prosopis africana Seed Gum as an Extended Release Polymer for Tablet Formulation.
    Nadaf S; Nnamani P; Jadhav N
    AAPS PharmSciTech; 2015 Jun; 16(3):716-29. PubMed ID: 25523143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, characterization and in vitro evaluation of 5-aminosalicylic acid loaded N-succinyl-chitosan microparticles for colon specific delivery.
    Mura C; Nácher A; Merino V; Merino-Sanjuán M; Manconi M; Loy G; Fadda AM; Díez-Sales O
    Colloids Surf B Biointerfaces; 2012 Jun; 94():199-205. PubMed ID: 22341520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colon delivery of budesonide: evaluation of chitosan-chondroitin sulfate interpolymer complex.
    Kaur G; Rana V; Jain S; Tiwary AK
    AAPS PharmSciTech; 2010 Mar; 11(1):36-45. PubMed ID: 20017011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of HPMC - E15 LV premium polymer on release profile and compression characteristics of chitosan/ pectin colon targeted mesalamine matrix tablets and in vitro study on effect of pH impact on the drug release profile.
    Newton AM; Lakshmanan P
    Recent Pat Drug Deliv Formul; 2014 Apr; 8(1):46-62. PubMed ID: 24597626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QbD approach of rapid disintegrating tablets incorporating indomethacin solid dispersion.
    Sammour OA; Hammad MA; Zidan AS; Mowafy AG
    Pharm Dev Technol; 2011 Jun; 16(3):219-27. PubMed ID: 20163325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy.
    Bellur Atici E; Karlığa B
    J Pharm Biomed Anal; 2015 Oct; 114():330-40. PubMed ID: 26099262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. To evaluate the effect of addition of an anionic surfactant on solid dispersion using model drug indomethacin.
    Dave RH; Patel AD; Donahue E; Patel HH
    Drug Dev Ind Pharm; 2012 Aug; 38(8):930-9. PubMed ID: 22085470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polysaccharide matrices for microbially triggered drug delivery to the colon.
    Sinha VR; Kumria R
    Drug Dev Ind Pharm; 2004 Feb; 30(2):143-50. PubMed ID: 15089048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of an extended-release matrix tablet using chitosan/Carbopol interpolymer complex.
    Park SH; Chun MK; Choi HK
    Int J Pharm; 2008 Jan; 347(1-2):39-44. PubMed ID: 17662544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of chitosan and chitosan/Kollicoat® Smartseal 30 D film-coated tablets for colon targeting.
    Drechsler M; Garbacz G; Thomann R; Schubert R
    Eur J Pharm Biopharm; 2014 Nov; 88(3):807-15. PubMed ID: 25301294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.